<DOC>
	<DOCNO>NCT02412384</DOCNO>
	<brief_summary>Circulating tumor cell ( CTCs ) potential provide surrogate for'real-time biopsy ' tumor biological activity . Enumeration molecular characterization CTCs lung cancer could play important role diagnosis , predict risk tumor recurrence , provide novel target therapy biomarkers . In view fact , investigator want demonstrate value multiparameter flow cytometry detect human tumor cell lung cancer normal peripheral blood cryosurgery without dendritic cell ( DC ) -cytokine-induced killer ( CIK ) treatment , investigator also compare specificity reverse transcriptase polymerase chain reaction ( RT-PCR ) method .</brief_summary>
	<brief_title>The Detection Circulating Tumor Cells ( CTCs ) Patients With Lung Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment</brief_title>
	<detailed_description>1 day 2 day cryosurgery without DC-CIK treatment，approximately 17-mL ethylene diamine tetraacetic acid ( EDTA ) -blood draw vein puncture patient lung cancer healthy volunteer . The blood healthy volunteer use evaluate sensitivity specificity negative control cell . To avoid contamination skin cell , 2 mL blood discard study sample taken.Briefly , mononucleate cell separate blood Ficoll- Paque 20 min 1800g 4℃ . The interface cell remove washed , red blood cell ( RBCs ) remove use lysis buffer follow repeated wash . The mononuclear cell count aliquot RT-PCR multiparameter flow cytometry basis least 2-3×106 cell methodology . The cell pellet resuspend phosphate-buffered saline multiparameter flow cytometry Trizol reagent RT-PCR . Aim : Identification CTCs may lead good diagnosis prognosis could help choose adequate therapy .</detailed_description>
	<mesh_term>Neoplastic Cells , Circulating</mesh_term>
	<criteria>1 . Age:1875 2 . Karnofsky performance status &gt; 60 3 . Diagnosis lung cancer base histology current accept radiological measure . 4 . Classification tumor , node , metastasisclassification ( TNM ) stage : Ⅱ , Ⅲ , Ⅳ 5 . Will receive cryosurgery and/or DCCIK treatment 6 . Life expectancy : Greater 3 month 7 . Patients ' routine blood test , liver function kidney function obvious abnormality 8 . Ability understand study protocol willingness sign write informed consent document 1 . Patients primary tumor except lung cancer 2 . History coagulation disorder anemia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Lung Neoplasms</keyword>
	<keyword>Circulating Tumor Cells</keyword>
</DOC>